Many observations bear upon the cellular and molecular requirements for CD4 T cell activation. The interaction of CD4 T cells with dendritic cells (DC), central to the induction of most immune responses, is the most studied. However, leukocytes other than DC can dramatically affect the induction and differentiation of CD4 T cells into effector cells. We recently provided indirect evidence that in vivo CD4 T cooperation facilitates the activation of CD4 T cells. Here, we demonstrate that the activation of CD4 T cells, specific for the hen egg lysozyme (HEL) 105-120 peptide, is optimally achieved when BALB/c mice are immunized with additional MHC class II-binding HEL peptides in incomplete Freund's adjuvant. This cooperation cannot be mimicked by the coadministration of LPS or of an agonistic antibody to CD40, at the time of immunization. In contrast, OX40-OX40L interactions are necessary for CD4 T cell cooperation in that an OX40 agonistic antibody can replace, and an OX40L-blocking antibody can abrogate, CD4 T cell cooperation in situations where such cooperation would otherwise enhance the activation of CD4 T cells.
Introduction
The ability of CD4 T cells to help in the generation of cytotoxic CD8 T cells and antibody-secreting B cells has been extensively analyzed. We, and others, have published evidence that CD4 T cells can also help the activation of other CD4 T cells. We envisage that cooperative interactions between CD4 T cells enhance their activation and acquisition of effector function following initial priming by professional antigen presenting cells (APCs).
Classically, T cells are known to require both TCR-mediated as well as co-stimulatory signals for their optimal activation (1) . While the prototypical CD28/B7 co-stimulatory interaction is the most well characterized (2) , other signals, particularly those mediated by members of the tumor necrosis factor superfamily and their corresponding receptors, can serve to enhance T cell activation (3) . Of particular interest, in the study of CD4 T cell activation, is the OX40-OX40L interaction. OX40 was originally isolated from T cell blasts (4) and is expressed on activated CD4 T cells following co-stimulation through B7-CD28 interactions (5) . Ligation of OX40 on CD4 T cells enhances their survival (5, 6) , by promoting the expression of anti-apoptotic proteins, and increases their ability to produce IL-4 while inhibiting their differentiation into Treg cells (7) (8) (9) . Enhanced survival of effector CD4 T cells leads to their optimal accumulation and aids their transition into longlived memory cells (10) . The natural ligand for OX40, OX40L, is expressed on activated B cells and DC (11) , among other cell types (12) . A number of groups have successfully employed the stimulation of T cells through OX40 to enhance the generation of immunity, whereas others have shown that abrogating OX40-OX40L interactions can be beneficial in models of T cell driven autoimmunity (13, 14) . Although the stimulation of T cells via OX40 is mainly thought to be by APC expressing OX40L, T cell-T cell interactions are also possible since T cells express OX40L due to the linked genetic control of OX40 and OX40L (15) . The expression of OX40L by T cells has been found to be both functional and important in the maintenance of CD4 T cells following initial priming (16) . Taken together, the patterns and timing of expression of OX40 and OX40L, along with findings that these molecules are often induced following initial interactions between APC and T cells, indicate that the role of the OX40-OX40L interaction is often secondary to initial priming and aids in the optimal expansion and survival of CD4 T effector cells, properties that are also associated with CD4 T cell help.
Several studies have been published supporting the hypothesis that CD4 T cells can cooperate with one another to enhance the generation CD4 T effector cells during primary immune responses. However, these systems employed high densities of TCR-transgenic T cells (16) , allo-reactive T cells in mixed lymphocyte reaction-type cultures (17) , previously activated T cells (18) , or DNA vaccination protocols that targeted expression of proteins to subsets of APC (19, 20) . Because these experimental systems are somewhat artificial, their physiological relevance is unclear.
Recently, we reported that CD4 T cells specific for a given peptide of hen egg lysozyme (HEL) were required to optimally activate CD4 T cells specific for other HEL peptides when a normal mouse is immunized with HEL (21) . BALB/c mice, made tolerant to a single and dominant HEL peptide, prior to immunization with the intact HEL protein, fail to generate CD4 T effector cells that respond to other HEL peptides. These observations provide indirect evidence for the importance of cooperation between endogenous CD4 T cells in the activation of other CD4 T cells. The ability of T cell cooperation to enhance the generation of effector CD4 T cells led us to suggest that, at least in some cases, the priming of a CD4 T cell by a 'classically activated' APC may be insufficient for the optimal generation of effector CD4 T cells. We envisage that such CD4 T cell interactions may occur after the initial wave of DC recruitment to the draining lymph nodes (22) and may modulate ongoing responses to antigen.
Here, we describe a system directly demonstrating CD4 T cell cooperation, thus providing a means for analyzing how such cooperation occurs. We show that single peptidespecific populations of CD4 T cells can cooperate with one another in vivo and that this cooperation depends on OX40-OX40L interactions.
Methods

Mice
BALB/c mice, aged between 6 and 10 weeks, were obtained from the College of Medicine animal facility at the University of Saskatchewan or from Charles River Canada (Sherbrooke, Canada). Sex and age were kept constant within experiments. All experiments were conducted under a protocol approved by the University of Saskatchewan's Animal Research Ethics Board that adhered to the Canadian Council on Animal Care guidelines for humane animal use.
Antigens and synthetic peptides
For ALUM immunization, HEL (grade VI; Sigma, St Louis, MO, USA) was aggregated as previously described (23) . The peptides of HEL, HEL [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] (AMKRHGLDNYRGYSL), HEL [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] (DGSTDYGILQINSRWW), HEL 74-96 (NLCNIPCSALLSSDITASV-NCAK) and HEL 105-120 (MNAWVAWRNRCKGTDV), as well as chicken ovalbumin peptide, OVA 323-339 (ISQAVHAAHAEI-NEAGR), were synthesized by the Alberta Peptide Institute (Edmonton, Canada) or by GenScript (Piscataway, NJ, USA) and were >95% pure, as assessed by mass sprectroscopy. All peptide antigens were dissolved in PBS and stored at À80C until needed.
ELISpot assay
Analysis of antigen-/peptide-specific cytokine secretion was accomplished by employing an improved ELISpot assay as previously described (21, 23, 24) . Briefly, a constant number of total splenocytes (1.5 3 10 6 ) were cultured overnight in primary antibody-coated nitrocellulose-bottom wells with and without antigen. After development of cytokine spots, antigen-dependent spots were enumerated by subtracting the numbers of spots counted in wells not supplemented with antigen from the number of spots counted in wells that were supplemented with antigen. Given that the number of cells in the spleen of mice treated differently can vary, all ELISpot data was normalized per spleen.
Immunizations
In some cases, to generate HEL-specific immune responses, mice were injected intraperitoneally with 200 lL of a 1:1 mixture of heat-aggregated HEL protein in PBS with Alhydrogel(R) 2% aluminum hydroxide gel adjuvant (ALUM; Superfos Biosector a/s, Vedbaek, Denmark). Immunizations with incomplete Freund's adjuvant (IFA) were prepared by making a 1:1 mixture of the appropriate peptide(s) in PBS with incomplete Freund's adjuvant (Sigma). In some cases, this IFA was supplemented with 5 lg/mouse of Escherichia coli serotype O111:B4 LPS (Sigma). Mice were immunized with 100 lL of the IFA emulsion subcutaneously at the base of the tail.
Antibodies
The CD40 agonist antibody FGK45, the corresponding isotype-matched control antibody 2A3, the OX40 (CD134) agonist OX86, and its corresponding isotype-matched control antibody HRPN, were obtained from Bio-X-Cell (West Lebanon, NH, USA). The OX40L (CD252) blocking antibody RM134L and the corresponding rat IgG2b control antibody were obtained, in functional grade, from eBioscience (San Diego, CA, USA) or from Bio-X-Cell.
Results
Simultaneous administration of two MHCII-binding peptides results in the enhanced generation of effector CD4 T cells
Our objective was to observe in vivo cooperation between endogenous CD4 T cells as directly as possible. We therefore chose to immunize mice with two carefully selected peptides, OVA 323-339 and HEL [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] , that bind to I-A d and I-E d , respectively, in BALB/c mice (25, 26) ; this enabled us to selectively stimulate two specific populations of CD4 T cells while avoiding peptide competition for binding to MHC.
We injected mice with IFA containing either a single peptide or both peptides. Ten days following immunization, we observed clear and significant increases in the numbers of cytokine producing CD4 T cells specific for HEL 105-120 in mice given both HEL 105-120 and OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] in IFA compared with the numbers generated in mice given HEL 105-120 alone (H versus H + O in Fig. 1 ). Interestingly, we did not observe significant increases in OVA 323-339 -specific CD4 T-effector cell generation between mice given OVA 323-339 alone and those given both peptides together. This observation may 2 Direct demonstration of CD4 T cell cooperation
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be attributed to differences in the level of pre-existing activation in CD4 T cells specific for OVA 323-339 in naive mice, or perhaps it is reflective of a larger baseline number of CD4 T cells specific for this peptide.
These observations, to the best of our knowledge, are the first to demonstrate that cooperation between CD4 T cells specific for two single MHCII-binding peptides can occur in vivo between endogenous populations of CD4 T cells. HEL 105-120 -specific CD4 T cells emerged as convenient targets for cooperation as it appears that, under these circumstances, cooperation is required for the generation of maximal numbers of cytokine secreting cells. We thus undertook experiments to investigate the mechanisms involved in this cooperation.
OVA 323-339 -specific CD4 T cells are required for the enhanced generation of HEL 105-120 -specific effector CD4 T cells upon simultaneous administration of both peptides Given that OVA 323-339 -specific effector CD4 T cells were generated equally well whether OVA 323-339 was administered alone or together with HEL 105-120 , it was possible that the enhanced generation of HEL 105-120 -specific effector T cells was due to properties of our OVA 323-339 preparation and not directly due to cooperation between the CD4 T cell populations. One of the ways that the OVA 323-339 preparation could increase the HEL 105-120 -specific response is via the presence of enhanced TLR stimulation of APC. Though peptides were routinely monitored for sterility, contamination of the OVA 323-339 with bacteria could lead to enhanced activation of APC-presenting peptide and thus result in more efficient effector CD4 T cell generation. To address this possibility, we assessed whether the addition of LPS to HEL [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] in IFA enhanced T cell responses to this peptide. Even in the presence of substantial amount of LPS that in similar systems enhances presentation of soluble peptides (27), we did not observe enhanced activation of CD4 T cells specific for HEL [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] (Fig. 2a) . Furthermore, upon systemic APC activation with an agonist antibody to CD40 (28), the generation of HEL 105-120 -specific CD4 effector T cells was not enhanced (Fig. 2b) . Taken together, these observations make it unlikely that nonspecific activation of APC is somehow responsible for the enhanced HEL 105-120 response; rather, these results lead us to suggest that APC-presenting HEL 105-120 are already efficiently activated by the presence of IFA alone, as even potent stimulation through CD40 did not enhance the activation of HEL 105-120 -specific CD4 T cells.
To directly address whether OVA 323-339 -specific CD4 T cells were required for the enhanced generation of HEL 105-120 -specific cytokine producing cells, we repeated the experiment, shown in Fig. 1 , in mice made tolerant to OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] . Since the administration of high doses of soluble OVA 323-339 results in anergy and subsequent deletion of peptide-specific CD4 T cells (29), we employed this strategy to specifically remove these cells as a cooperating population. Corresponding with the drop in the generation of OVA 323-339 -specific effector T cells, the enhanced generation of HEL 105-120 -specific cytokine producing cells was absent in OVA 323-339 tolerant mice (Fig. 3) . To confirm that the tolerization procedure did not nonspecifically prevent the generation of HEL 105-120 -specific effectors, we replaced the anergic/deleted endogenous OVA 323-339 -specific CD4 T cells with purified DO11.10 CD4 T cells bearing a transgenic TCR that recognizes OVA 323-339 in the context of I-A d (30) . As shown in Fig. 3 , adoptively transferred DO11.10 T cells to OVA 323-339 tolerant mice were able to facilitate the optimal production of HEL 105-120 -specific effector CD4 T cells.
These results indicate that the enhanced generation of HEL 105-120 , on coadministration of the two peptides, results from cooperation between HEL 105-120 -specific CD4 T cells and OVA 323-339 -specific CD4 T cell populations. Cooperation occurs between T cell populations specific for peptides derived from the same nominal antigen Although our observations demonstrate that two populations of CD4 T cells specific for two peptides from two unrelated proteins can cooperate in vivo, we wished to extend our findings into a more physiologically relevant system. Normally, immunization of BALB/c mice with HEL protein gives rise to CD4 T effector cells that recognize four different MHCII-restricted peptides; HEL [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , HEL 48-63 , HEL 74-96 and HEL 105-120 ( Figure S1 , available at International Immunology Online; (23)). We therefore wished to determine whether the simultaneous administration of multiple peptides derived from the same nominal antigen, HEL, would result in cooperation among the CD4 T cell populations specific for these peptides. Since we had already shown that cooperation between OVA 323-339 and HEL 105-120 -specific T cells greatly enhances the generation of HEL 105-120 -specific CD4 T effector cells, we administered the HEL 105-120 peptide alone or with the three other HEL peptides together in IFA. In agreement with our previous findings, we observed enhanced generation of CD4 T effector cells specific for HEL 105-120 when all four HEL peptides were administered together in IFA compared with when HEL 105-120 was given alone (Fig. 4) . We were able to detect cytokine producing CD4 T cells specific for the I-A d -binding peptide HEL [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] when all four peptides were given together ( Figure S2 , available at International Immunology Online). We have also observed cooperative interactions between HEL 11-25 and HEL 105-120 alone (data not shown).
Peptide-dependent ELISpot forming cells per spleen
This finding leads us to suggest that, under normal conditions, peptides derived from intact proteins have the potential to elicit cooperation among suitably specific CD4 T cells and that such cooperation may occur during responses to many protein antigens.
OX40-OX40L interactions are critical for cooperation between CD4 T cells
Previous studies have indicated a role for both CD40-CD40L and OX40-OX40L interactions in the generation of optimal numbers of CD4 effector T cells (16, 20) . We therefore wished to investigate whether these interactions played a significant role in the cooperation that we observed upon simultaneous administration of the four HEL peptides. Since we had shown that an agonist antibody to CD40 did not affect the generation of cytokine producing CD4 T cells specific for HEL 105-120 when that peptide was given alone, we asked whether directly stimulating T cells through an agonist to OX40 could. We observed a very potent increase in the number of HEL 105-120 -specific T cells following the administration of anti-OX40 agonistic antibody to mice immunized with HEL 105-120 in IFA (Fig. 5) . The effect of the anti-OX40 antibody was highly specific in that enhanced peptidespecific cytokine production was only observed when the appropriate peptide was administered at the time of antibody administration ( Figure S3 , available at International Immunology Online). We also found that the administration of a noncytolytic blocking antibody to OX40L inhibited the enhanced generation of HEL 105-120 -specific T cells in mice given all four HEL peptides. In contrast, blocking OX40L had very little effect on the HEL 105-120 -specific response generated upon administration of HEL 105-120 alone (Fig. 6) . Thus, it appears that OX40-OX40L interactions are critically involved only in the enhancement of CD4 T effector cell generation mediated by CD4 T cell cooperation, and not simply in the activation of naive CD4 T cells. This finding supports the hypothesis that cooperation between populations of CD4 T cells depends on eliciting OX40L expression on either APC populations or CD4 T cells. Unfortunately, this experimental system does not allow for the identification of the cell type responsible for the provision of OX40L, as peptideloaded APC and peptide-specific T cells are extremely scarce. Ongoing experiments in our laboratory are aimed at addressing this question.
Stimulation of OX40 rescues all HEL peptide-specific CD4 T effector cell responses lost upon making mice tolerant to a single HEL peptide Our previous work (21) 
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ALUM. The generation of CD4 effector T cells specific for the other HEL peptides could be rescued by immunizing with HEL coupled to OVA, thus replacing the HEL 105-120 -specific cooperating CD4 T cells with an OVA-specific CD4 T cell population. Given our finding that OX40 stimulation mimics, and blocking OX40L abrogates, the effects of CD4 T cell cooperation (Figs. 5 and 6), it was natural to assess whether OX40 stimulation could rescue the generation of HEL peptide-specific CD4 effector cells in HEL 105-120 tolerant mice immunized with HEL on ALUM.
As shown in Fig. 7 , the responses to the HEL [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , HEL 48-63 and HEL peptides are lost in HEL 105-120 tolerant animals upon immunization with HEL protein on ALUM. Significantly, these responses are rescued upon stimulation with an agonistic antibody to OX40. Treatment with anti-OX40 antibody also rescued the generation of HEL 105-120 -specific CD4 T cells in . HEL 105-120 -specific effector CD4 T cell generation is greatly enhanced by coadministration of an OX40 agonist antibody. BALB/c mice were immunized with 10 lg of HEL 105-120 alone, subcutaneously in IFA, and were treated with 100 lg of either an isotype-matched control antibody or an OX40 agonist antibody, intravenously at the time of immunization. The cytokine producing effector CD4 T cells, specific for HEL 105-120 , were enumerated by optimized ELISpot assay 10 days post-immunization. Each data point represents the total number of ELISpot forming cells detected in the spleen of a single mouse. These are pooled results from three independent experiments. P-values represent the probability that the means of the two samples indicated are not different as assessed by unpaired two-tailed T tests.
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line with previous findings (31) . Given that the level of minor peptide-specific effector T cells generated in HEL 105-120 tolerized mice was much greater than in normal mice, and our findings that minor peptide-specific CD4 T effector cells can be stimulated directly by anti-OX40 ( Figure S3 , available at International Immunology Online), we suggest that the effect of agonist antibody treatment, on the generation of CD4 T cells specific for minor HEL peptides, is likely due to a combination of cooperation resulting from the rescue of the HEL 105-120 -specific CD4 T cells and the direct action of the agonistic antibody on minor peptide-specific CD4 T cells.
Discussion
Through the experiments presented in this study, we were able to observe cooperation between populations of CD4 T cells in a direct and simple manner. In our systems, activation of endogenous CD4 T cells specific for HEL 105-120 is aided by simultaneous administration of peptides that activate other endogenous naive CD4 T cells (Figs. 1 and 4) . We have shown that the enhanced generation of HEL 105-120 -specific CD4 effector T cells when HEL 105-120 and OVA 323-339 are given together requires the presence of OVA 323-339 -specifc CD4 T cells (Fig. 3) . We therefore conclude that our observations reflect true cooperation between peptide-specific populations of CD4 T cells and are not simply due to nonspecific and stimulatory properties of our peptide preparations. We further demonstrate that cooperation between CD4 T cells, specific for peptides derived from the same nominal antigen, can enhance the activation of a single peptidespecific CD4 T cell population. Given this result, we propose that CD4 T cell cooperation may occur in response to many different proteins. [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] . BALB/c mice were treated with saline or were treated with soluble HEL 105-120 , as in Fig. 3 . Fourteen days later, all mice were challenged with 100 lg of heataggregated HEL on ALUM intraperitoneally. Some mice were treated with 100 lg of an isotype-matched control antibody while some tolerant mice were treated with 100 lg of an OX40 agonist antibody intravenously at the time of immunization. The cytokine producing effector CD4 T cells, specific for four different HEL peptides, were enumerated by optimized ELISpot assay 10 days post-immunization. Each data point represents the total number of ELISpot forming cells detected in the spleen of a single mouse. These are pooled results from three independent experiments. P-values represent the probability that the means of the two samples indicated are not different as assessed by unpaired two-tailed T tests.
In addition to directly observing CD4 T cell cooperation, we have attempted to elucidate the underlying molecular interactions involved. We demonstrate that stimulation of CD4 T cells with an agonist antibody to OX40 greatly enhances the number of cytokine producing effector cells generated upon immunization with single peptides in IFA. This adjuvant effect has been seen by others and employed to enhance immunity to protein antigens (10) and tumors (32, 33) . Moreover, we demonstrate that blocking OX40L, in an experimental setting where cooperation enhances the generation of peptide-specific CD4 effector T cells, completely abrogates the effect of cooperation. However, it is clear from our data (Fig. 6 ) that peptide-specific responses do not require OX40L. We interpret this finding to mean that the major role for the OX40-OX40L interaction, in our experimental system, is in maximizing responses through CD4 T cell cooperation.
Given these results, a natural question is: What is the source of OX40L? Our experimental system, because it is based on stimulation of endogenous polyclonal T cells by administration of peptides administered in IFA, does not allow for the ready analysis of either the T cells or the APC involved in the generation of anti-HEL 105120 responses. Bulk analysis of cells from the spleen or draining lymph nodes has not been incisive as the cells involved in the cooperative events are scarce, and so do not dominate any cell population (unpublished observations). We are currently working on determining the identity and phenotype of the APC and T cells involved in CD4 T cell cooperation in a different experimental setting designed to achieve these aims. However, there are only two main possibilities, given our current knowledge, for the source of OX40L in this system. Firstly, OX40L expression may be elicited on DC or other APC, such as B cells, following their interaction with T cells specific for one of the administered peptides. Thus, APC would be 'licensed' to become even more potent activators of CD4 T cells upon interaction with one or more CD4 T cells. Alternatively, the recognition by T cells of peptide-MHC-complexes, in association with conventional co-stimulatory signals, may induce OX40L expression on the T cells themselves. Cooperation could therefore occur via T cell-T cell contacts around APC that simultaneously present both peptides, In either case, a cascade of T cell-APC and/or T cell-T cell interactions would then ensue, enhancing the generation of CD4 effector T cells.
The well-described CD40-CD40L interaction serves to activate DC and B cells that interact with T cells expressing CD40L. Ligation of CD40 on B cells serves to greatly enhance the expression of OX40L in vitro (34) . In some models, activation by CD40 alone is sufficient to 'license' DC to directly prime CD8 T cells (35) . A similar series of events may occur in CD4 T cell cooperation. We assessed whether the administration of an agonist antibody to CD40 could replace the effects of CD4 T cell cooperation and found no effect. However, anti-CD40 treatment activates the vast majority of B cells and DC in a treated animal (28) and is reflected in a 4-fold increase in the cellularity of the spleen (21) . This approach may, therefore, lead to a dilution of peptide-specific T cell interactions by increasing the number and intensity of nonantigen-specific T cell-APC contacts made during the generation of immune responses. Thus, while we can conclude that the administration of an anti-CD40 agonistic antibody cannot replace CD4 T cell cooperation, we cannot strictly rule out a role for CD40-CD40L interactions in this cooperation.
Finally, we wish to point out two biologically important situations where the CD4 T cell cooperation we describe might be important. It is generally found that the administration of single peptides, able to bind to host class II MHC molecules, poorly activate their corresponding CD4 T cells, unless given in a few selected adjuvants, such as CFA. Indeed, even some relatively small proteins, such as xenogeneic cytochrome C, are often not very immunogenic on their own. This kind of finding is expected if CD4 T cell cooperation often facilitates the activation of CD4 T cells, a conclusion with obvious implications for vaccination. Secondly, the phenomenon of 'epitope-spreading' is a well-known phenomenon in both human and animal autoimmune disease (reviewed in (36) ). The presence of CD4 T cells specific for one epitope of an autoantigen facilitates the generation of CD4 T cells specific for other epitopes of the auto-antigen. Some have suggested this phenomenon may be due to the fact that the initial immunity may lead to the release of more auto-antigen, or the generation of new peptides of the auto-antigen. We suggest, in addition to these mechanisms, that CD4 T cell cooperation, in the activation of autoreactive CD4 T cells, may be pertinent.
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